Aberdeen Group’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Aberdeen Group's CDNA Position: Q2 2026 in Review
Aberdeen Group reduced its CareDx (CDNA) stake by 46% in Q2 2026, selling an estimated $4.2M and leaving 224,829 shares worth $6.41M. The position accounts for 0.01% of the portfolio, ranked #667.
Aberdeen Group first reported a position in CDNA in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.25M in Q1 2026. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Aberdeen Group held 224,829 shares of CareDx worth $6.41M as of Q2 2026.
- Aberdeen Group sold 192,915 CareDx shares in Q2 2026, an estimated $4.2M.
- CareDx made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #667 holding.
- Aberdeen Group first reported a position in CareDx in Q4 2025 and has held it in 3 quarters since.
- Aberdeen Group's CareDx position peaked at $7.25M in Q1 2026.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.